Promethium Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.28M Buy
25,675
+401
+2% +$93.4K 3.25% 6
2025
Q4
$5.23M Buy
25,274
+844
+3% +$167K 2.82% 6
2025
Q3
$4.53M Buy
24,430
+110
+0.5% +$18.8K 2.6% 7
2025
Q2
$3.71M Buy
24,320
+1,456
+6% +$224K 2.26% 9
2025
Q1
$3.79M Buy
22,864
+2,902
+15% +$454K 2.43% 8
2024
Q4
$2.89M Buy
19,962
+4,413
+28% +$684K 1.98% 14
2024
Q3
$2.52M Buy
+15,549
New +$2.48M 1.78% 14

Other funds holding JNJ

Promethium Advisors's JNJ Position: Q1 2026 in Review

Promethium Advisors increased its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, buying an estimated $93.4K and bringing the position to 25,675 shares worth $6.28M. The position accounts for 3.25% of the portfolio, ranked #6.

Promethium Advisors first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Promethium Advisors held 25,675 shares of Johnson & Johnson worth $6.28M as of Q1 2026.
  • Promethium Advisors bought 401 Johnson & Johnson shares in Q1 2026, an estimated $93.4K.
  • Johnson & Johnson made up 3.25% of Promethium Advisors's portfolio in Q1 2026, its #6 holding.
  • Promethium Advisors first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.